Comparing Stiolto Respimat vs Trelegy Ellipta
| Stiolto Respimat (olodaterol / tiotropium) | Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) |
|
|---|
| Stiolto Respimat (olodaterol / tiotropium) | Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for COPD - Maintenance, COPD. Stiolto Respimat may also be used for purposes not listed in this medication guide. |
Prescription only
Trelegy Ellipta is approved for the once-daily treatment of adults with chronic obstructive pulmonary disease (COPD) or for adults with asthma. Trelegy Ellipta is an option for the treatment of... View more |
Related suggestions |
|||||||||||||||
| More about Stiolto Respimat (olodaterol / tiotropium) | More about Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Stiolto Respimat has an average rating of 7.3 out of 10 from a total of 48 ratings on Drugs.com. 63% of reviewers reported a positive effect, while 17% reported a negative effect. |
Trelegy Ellipta has an average rating of 6.8 out of 10 from a total of 257 ratings on Drugs.com. 58% of reviewers reported a positive effect, while 23% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Stiolto Respimat side effects |
View all Trelegy Ellipta side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Stiolto Respimat prices |
View all Trelegy Ellipta prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
25 hours |
24 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 426 drugs are known to interact with Stiolto Respimat:
|
A total of 538 drugs are known to interact with Trelegy Ellipta:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
May 21, 2015 |
September 18, 2017 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.